Dear EuroSIDA Study Investigators,

We hope that this email finds you all well.

We would like to send you this EuroSIDA newsletter with some updates that might be interesting for you. A more detailed newsletter will be shared with you coming this summer.

EuroSIDA reimbursement 2020 - delayed.

Due to a national lockdown and a temporary change in scientific priorities, our normal activities in EuroSIDA and in cohort studies, in general, have slowed down considerably and many deadlines have been postponed.  

The reimbursement process planned for May/June 2020 regrettably has to be postponed, but will of course still be made in 2020. As soon as we know when we will be able to make the reimbursement, we will inform you.

CHIP's input into SARS-CoV-2 treatment trials. 

CHIP is International Coordinating Centre (ICC) and together with the London ICC, CHIP is overseeing the European arm of the Adaptive COVID-19 Treatment Trial (ACTT). The global  ACTT trial is coordinated by the INSIGHT research network and sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) under NIH. 

The preliminary results of the first randomised study show that people infected with the SARS-CoV-2 recover 31% faster if they receive Remdesivir. 

More information available in the press release from National Institutes of Health (NIH) and video with NIAID Director Dr Anthony Fauci providing an update on the Remdesivir drug.

Free webinar from Spring European Testing Week on HIV self-testing

The upcoming Spring European Testing Week is 15-22 May is taking place online this year. It aims to advocate and raise awareness on the importance of HIV, viral hepatitis and STI services (in line with a recent call from UNAIDS) through online platforms and to also share how you and your organisation is supporting your community during this global pandemic.

As part of ETW’s activities, they are hosting a FREE live webinar next Tuesday, 19 May from 16:00-17:00 CEST.

With the current global COVID-19 pandemic, interest for HIV self-testing/sampling has been rapidly increasing due to service closures and/or restrictions to in-person testing. However, in some countries, there exist gaps in knowledge on HIV self-testing/sampling where they may not be widely known or easily available.

This webinar will present case examples from Lithuania (Asociacija Demetraand Italy (Arcigay/Lila Milano) where pilot activities were undertaken through the INTEGRATE JA (led by partners at Public Health England) to close the knowledge gaps to understand the HIV self-testing situation in both countries. These pilots implemented activities to assess awareness, usability, acceptability, availability and knowledge of self-tests and the findings will be presented in the webinar.

Register for the webinar here -


Why are you receiving this email?

You are receiving this email because you are affiliated with the EuroSIDA study. By providing your contact details to the EuroSIDA Coordinating Centre, you are included in the mailing list for the EuroSIDA study.

Please always feel free to contact the EuroSIDA coordinating centre at
No question is too small or too big, we are happy to assist in all matters!

Copyright © 2020 Rigshospitalet, CHIP, All rights reserved.
You are receiving this email because you are affiliated with the  EuroSIDA study.

Our mailing address is:
Rigshospitalet - University of Copenhagen
CHIP, Department of Infectious Diseases, Section 2100
Centre for Cardiac, Vascular, Pulmonary and Infectious Diseases
Blegdamsvej 9
DK-2100 Copenhagen Ø,

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.